Resilience And Harvard University Announce Five-Year R&D Alliance To Incubate New Technologies, Launch Companies To Advance The Manufacture Of Complex Medicines
SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--National Resilience, Inc. (Resilience), a manufacturing and technology company, and Harvard University have established a five-year research and development alliance with a $30 million commitment from Resilience directed toward the development of complex medicines, including biologics, vaccines, nucleic acids and cell and gene therapies.
Click here to read the full press release from Business Wire.
